The effect of plasma lipids and lipid lowering interventions on bone mineral density: a Mendelian randomization study
暂无分享,去创建一个
David M. Evans | N. Warrington | J. Kemp | G. Smith | G. Hemani | P. Haycock | M. Ala-Korpela | M. Borges | J. Tobias | T. Richardson | Jie Zheng | Marie-Jo Brion | Z. Qiao | Zhen Qiao | David M. Evans | David M. Evans | M. Brion
[1] R. Eckel,et al. Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review , 2018, Current Diabetes Reports.
[2] Julian M. W. Quinn,et al. An Atlas of Human and Murine Genetic Influences on Osteoporosis , 2018, bioRxiv.
[3] G. Davey Smith,et al. Evaluating the potential role of pleiotropy in Mendelian randomization studies , 2018, Human molecular genetics.
[4] P. Visscher,et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700,000 individuals of European ancestry , 2018, bioRxiv.
[5] Valeriia Haberland,et al. The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.
[6] G. Davey Smith,et al. Orienting the causal relationship between imprecisely measured traits using GWAS summary data , 2017, PLoS genetics.
[7] Raquel S. Sevilla,et al. Exome-wide association study of plasma lipids in >300,000 individuals , 2017, Nature Genetics.
[8] Jacqueline K. White,et al. Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis , 2017, Nature Genetics.
[9] M. McCarthy,et al. Bone mineral density and risk of type 2 diabetes and coronary heart disease: A Mendelian randomization study , 2017, Wellcome open research.
[10] Hashem A. Shihab,et al. MR-Base: a platform for systematic causal inference across the phenome using billions of genetic associations , 2016, bioRxiv.
[11] Szilard Voros,et al. Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes. , 2016, The New England journal of medicine.
[12] S. Thompson,et al. Bias due to participant overlap in two‐sample Mendelian randomization , 2016, Genetic epidemiology.
[13] N. Sheehan,et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic , 2016, International journal of epidemiology.
[14] David M. Evans,et al. Using Mendelian randomization to investigate a possible causal relationship between adiposity and increased bone mineral density at different skeletal sites in children , 2016, International journal of epidemiology.
[15] Tom R. Gaunt,et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis , 2016, bioRxiv.
[16] D. Gudbjartsson,et al. Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease , 2016, Nature Genetics.
[17] Zhenhao Piao,et al. Effects of Statins on Bone Mineral Density and Fracture Risk , 2016, Medicine.
[18] G. Davey Smith,et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.
[19] Mitchell J. Machiela,et al. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..
[20] David M. Evans,et al. Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. , 2015, Annual review of genomics and human genetics.
[21] R. Brook,et al. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study. , 2015, Journal of the American College of Cardiology.
[22] M. Daly,et al. An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.
[23] G. Davey Smith,et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.
[24] N. Timpson,et al. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors , 2015, European Journal of Epidemiology.
[25] F. Dudbridge,et al. Re: "Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects". , 2015, American journal of epidemiology.
[26] S. Thompson,et al. Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects , 2015, American journal of epidemiology.
[27] A. Butterworth,et al. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways , 2014, International journal of epidemiology.
[28] M. Daly,et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.
[29] Tanya M. Teslovich,et al. Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.
[30] A. Butterworth,et al. Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.
[31] D. Ye,et al. HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis. , 2013, Bone.
[32] Daniel L. Koller,et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture , 2012, Nature Genetics.
[33] R. Eastell,et al. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high‐bone‐mass phenotype due to a mutation in Lrp5 , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] T. Frayling,et al. C-reactive protein levels and body mass index: Elucidating direction of causation through reciprocal Mendelian randomization , 2010, International Journal of Obesity.
[35] U. Ersoy,et al. Ezetimibe Effect on Bone Mineral Density and Markers of Bone Formation and Resorption , 2010, Journal of Investigative Medicine.
[36] J. Nyman,et al. Local Low-Dose Lovastatin Delivery Improves the Bone-Healing Defect Caused by Nf1 Loss of Function in Osteoblasts , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] George Davey Smith,et al. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.
[38] M. McKee,et al. Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.
[39] N. Sheehan,et al. Mendelian randomization as an instrumental variable approach to causal inference , 2007, Statistical methods in medical research.
[40] S. Rossi,et al. Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men , 2005, Osteoporosis International.
[41] John J. Shin,et al. Osteoporosis and cardiovascular disease , 2004, Endocrine.
[42] F. Parhami. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[43] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[44] F. Parhami,et al. Role of the Cholesterol Biosynthetic Pathway in Osteoblastic Differentiation of Marrow Stromal Cells , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[45] D. Shih,et al. The role of high-density lipoproteins in oxidation and inflammation. , 2001, Trends in cardiovascular medicine.
[46] S. Manolagas,et al. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.
[47] F. Parhami,et al. Atherogenic Diet and Minimally Oxidized Low Density Lipoprotein Inhibit Osteogenic and Promote Adipogenic Differentiation of Marrow Stromal Cells , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[48] F. Parhami,et al. Arterial calcification in face of osteoporosis in ageing: can we blame oxidized lipids? , 1997, Current opinion in lipidology.
[49] R. Jilka,et al. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.
[50] W. G. Cochran. The comparison of percentages in matched samples. , 1950, Biometrika.
[51] W-W Wang,et al. Association between lipid profiles and osteoporosis in postmenopausal women: a meta-analysis. , 2018, European review for medical and pharmacological sciences.
[52] A. Moayyeri,et al. Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis , 2011, Osteoporosis International.
[53] P. Goes,et al. Effect of Atorvastatin in radiographic density on alveolar bone loss in wistar rats. , 2010, Brazilian dental journal.
[54] K. Ueki,et al. Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[55] M. Mastropasqua,et al. Cardiovascular disease and osteoporosis. , 2005, Journal of endocrinological investigation.
[56] G. Vigna,et al. Testosterone replacement, cardiovascular system and risk factors in the aging male. , 2005, Journal of endocrinological investigation.